Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study. PET in Recurrent Cancer(PETREC)

NCT00686465 is registered in ClinicalTrials.gov with Ontario Clinical Oncology Group (OCOG) as lead sponsor.

NCT NCT00686465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00686465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study. PET in Recurrent Cancer(PETREC)
Lead sponsor
Ontario Clinical Oncology Group (OCOG)
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2009
Completion date
July 31, 2012
Enrollment
101 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, esophageal cancer, head and neck cancer, lymphoma, non-small cell lung cancer, ovarian cancer